Stock CIM CHIMERA INVESTMENT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Chimera Investment Corporation

Equities

CIM

US16934Q2084

Real-time Estimate Cboe BZX
Other stock markets
 03:52:19 2024-05-03 pm EDT 		5-day change 1st Jan Change
4.315 USD +0.58% Intraday chart for Chimera Investment Corporation +2.98% -13.53%
Mar. 28 Chimera Investment Corporation Declares Cash Dividend for the First Quarter 2024, Payable April 30, 2024 CI
Mar. 13 IPOs: 2024 should be a vintage year Our Logo

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
UBS Downgrades Chimera Investment to Neutral From Buy, $5 Price Target
MT
UBS Initiates Coverage on Chimera Investment With Neutral Rating, $5.50 Price Target
MT
Credit Suisse Trims Chimera Investment's PT to $5.50 From $6.50 on Reduced Earnings Power, Expectations for Reduction in Dividend; Keeps Neutral Rating
MT
RBC Cuts Price Target on Chimera Investment to $6 From $7, Maintains Outperform Rating
MT
Keefe, Bruyette & Woods Adjusts Price Target on Chimera Investment to $6.25 From $7, Maintains Market Perform Rating
MT
RBC Cuts Price Target on Chimera Investment to $7 From $11, Noting Unexpected Dividend Cut, Maintains Outperform Rating
MT
Barclays Adjusts Price Target on Chimera Investment to $9 From $11, Reiterates Underweight Rating
MT
RBC Cuts Price Target on Chimera Investment to $11 From $15, Maintains Outperform Rating
MT
Barclays Adjusts Chimera Investment's Price Target to $11 from $14, Keeps Underweight Rating
MT
RBC Boosts Price Target on Chimera Investment to $18 From $16, Maintains Outperform Rating
MT
CHIMERA INVESTMENT : RBC Raises Price Target on Chimera Investment to $16 From $14, Maintains Outperform Rating
MT
CHIMERA INVESTMENT : RBC Boosts Price Target on Chimera Investment to $14 From $12.50, Maintains Outperform Rating
MT
CHIMERA INVESTMENT : RBC Capital Adjusts Chimera Investment's Price Target to $12.50 From $11, Maintains Outperform Rating
MT
CHIMERA INVESTMENT : Barclays Downgrades Chimera Investment to Underweight From Equal Weight; Trims PT to $10 From $11
MT
CHIMERA INVESTMENT : BTIG Starts Chimera Investment at Neutral
MT
CHIMERA INVESTMENT : RBC Capital Adjusts Chimera Investment's Price Target to $11 From $10, Maintains Outperform Rating
MT
Chimera Investment Corporation(NYSE:CIM.PRA) added to S&P U.S. Fixed Rate Preferred Stock Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CIM Stock
  4. News Chimera Investment Corporation
  5. Analyst Reco.